- Home
- / SyneuRx International
SyneuRx International
Stock Price
NT$16.3
2024-01-26
Market Capitalization
NT$2.1 B
2024-01-26
Revenue
NT$5 M
FY, 2024
SyneuRx International Summary
Company Summary
- Overview
- SyneuRx International is a biotech company that provides clinical drug services. It develops drugs for the treatment of unmet medical needs in the central nervous system, and other drug products.
- Type
- Public
- Status
- Active
- Founded
- 2013
- Website
- https://www.syneurx.com
- Cybersecurity rating
Table of Contents
SyneuRx International Financials
Summary Financials
- Revenue (FY, 2024)
- NT$5.0M
- Gross profit (FY, 2024)
- NT$3.9M
- Net income (FY, 2024)
- (NT$69.9M)
- Cash (FY, 2024)
- NT$50.4M
- EBIT (FY, 2024)
- (NT$69.3M)
- Enterprise value
- $2.1B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026